|文摘: ||Regulatory T cells are essential components of the immune system, and several different subsets of regulatory T cells have been described. Considerable regulatory function has been attributed to the CD4+CD25+ T cell subset. These cells act by suppressing adaptive and possibly innate immune responses thereby maintaining or restoring the balance between immunity and tolerance. The suppressive effects of CD4+CD25+ regulatory T cells are cell-contact dependent but a role for soluble factors, particularly in vivo, has been suggested as well.
Recent developments and viewpoints in the field of CD4+CD25+ regulatory T cells as well as the potential use of regulatory T cells in immunotherapy of inflammatory diseases are discussed in this volume. By linking data from experimental models with recent findings from the clinic, this book is of interest to immunologists and other biomedical researchers as well as clinicians interested in the regulation and manipulation of the immune response during inflammatory disease.
From the contents:Part I: Origin, function and distribution of regulatory T cells.- History of CD25+CD4+ regulatory T cells. 揘atural?and 搃nduced?regulatory T cells - purpose and problems associated with an emerging distinction. The role of interleukin-10 in regulatory-T-cell suppression: reconciling the discrepancies. Activation and distribution of regulatory T cells in naive and antigen-stimulated immune systems. Regulatory T cells and the innate immune system.- Part II: The potential use of regulatory T cells in immunotherapy.- Exploiting the potential of regulatory T cells in the control of type 1 diabetes. Regulatory T cells in type 1 autoimmune diabetes. The potential for targeting CD4+CD25+ regulatory T cells in the treatment of multiple sclerosis in humans. Immunotherapy of rheumatoid arthritis using CD4+CD25+ regulatory T cells. Potential for manipulation of regulatory T cells in treatment or prevention of allergic disease. The role of regulatory T cellsin cutaneous disorders.